Test 3 Flashcards
(128 cards)
Chapter 14: Pharmacology
What are the major mechanisms by which drugs cross the placenta?
- Ultrafiltration
- Simple diffusion
- Active transport
- Breaks in the placental villi
Chapter 14: Pharmacology
Drugs that are known to cause physical and/or mental development abnormalities in the embryo or fetus.
Teratogens, or teratogenic substances
Chapter 14: Pharmacology
__________ occurs as the placenta acts as a semipermeable membrane with maternal hydrostatic forces pushing drugs with low molecular weight through the fetal side.
Ultrafiltration
Chapter 14: Pharmacology
When the transfer of a drug across the placenta is aided by proteins in the membrane, it is called ____.
Facilitated diffusion
Chapter 14: Pharmacology
Uses energy from ATP to move drugs across the placenta membranes against the concentration gradient.
Active transport
Chapter 14: Pharmacology
Drug transfer across the placenta is determined by ________.
- Concentration difference across the placenta
- Lipid solubility of drug
- Degree of ionization of drug
- Molecular weight of drug
Chapter 14: Pharmacology
Some substances readily pass through the placenta to the fetus by _________, which is often the result of a concentration gradient existing between the mother and fetus.
Simple diffusion
Chapter 14: Pharmacology
Teratogens may cause:
- Spontaneous abortion
- Congenital malformations
- Intrauterine growth retardation
- Mental retardation
- Carcinogenesis
Chapter 14: Pharmacology
Which trimester is the most critical time for teratogens to have an effect?
First
Chapter 14: Pharmacology
Effects of teratogens depend on what factors?
- Dose that reaches fetus
- Length of exposure
- Gestational age of fetus at time of exposure
- Other drugs being taken by mother
Chapter 14: Pharmacology
What drug is linked to autism and NOT recommended to be taken during pregnancy?
Ibuprofen
Chapter 14: Pharmacology
General term for the process by which drugs enter the body (absorption), are distributed throughout the system (distribution), are changed or altered from original compound (metabolism) and eventually leave the body (excretion).
Pharmacokinetics
Chapter 14: Pharmacology
The primary site within the system where drug metabolism takes place is the ______.
Liver
- Also other areas such as the plasma, kidney and GI tract.
Chapter 14: Pharmacology
Medication used for supraventricular tachycardia
Adenosine
Chapter 14: Pharmacology
Used to reverse sinus bradycardia
Atropine
Chapter 14: Pharmacology
Used during resuscitation for the treatment of acute cardiovascular collapse.
Epinephrine
Chapter 14: Pharmacology
Used for atrial fibrillation, atrial flutter, paroxysmal atrial tachycardia, cardiogenic shock and all degrees of CHF.
Digoxin (Lanoxin)
Chapter 14: Pharmacology
Used to close a hemodynamically significant patent ductus arteriosus.
Indomethacin Sodium Trihydrate (Indocin IV)
Chapter 14: Pharmacology
Indicated for short-term treatment to increase CO due to decreased contractility from organ heart disease or cardiac surgical procedures
Dobutamine (Dobutrex)
__________ is indicated to maintain the patency of the ductus arteriosus until corrective surgery can be performed.
Alprostadil
_________ is indicated for the correction of hemodynamic imbalances present in the shock syndrome due to decreased cardiac function in congestive heart failure, trauma, endotoxic septicemia, renal failure, and myocardial infarction.
Dopamine
__________ is indicated for the treatment of persistent pulmonary hyper- tension of the newborn.
Tolazoline
Bumetanide is a ______ used in patients with congestive heart failure, renal insufficiency, or edema that is refractory to furosemide.
diuretic
As a diuretic, acetazolamide is often used in conjunction with furose- mide to slow the progression of _______ in patients who are not candidates for surgery.
hydrocephalus